Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Janus Kinase Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06691061
What this trial is testing

The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (Disorder)
Humanitas Clinical and Research Center 450
Testing effectiveness (Phase 2)Looking for participantsNCT06536166
What this trial is testing

Ruxolitinib Treatment in Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05743244
What this trial is testing

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 78
Large-scale testing (Phase 3)Study completedNCT00934544
What this trial is testing

Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 219
Testing effectiveness (Phase 2)Active Not RecruitingNCT07820098
What this trial is testing

Topical Delgocitinib for Facial Vitiligo

Who this might be right for
Vitiligo
Lone Skov 12
Large-scale testing (Phase 3)Study completedNCT03745638
What this trial is testing

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 631
Post-approval studies (Phase 4)UnknownNCT05153200
What this trial is testing

Early Changes in Pain, Disease Activity, and Ultrasound Evidence of Inflammatory Synovitis in Patients Receiving JAK-inhibitor vs. TNF-inhibitor Therapy for Active Rheumatoid Arthritis: A Feasibility Study.

Who this might be right for
Rheumatoid Arthritis
Ottawa Hospital Research Institute 40
Not applicableUnknownNCT05567380
What this trial is testing

Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sohag University 150
Post-approval studies (Phase 4)Study completedNCT07368673
What this trial is testing

Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial

Who this might be right for
Vitiligo
Dow University of Health Sciences 120
Large-scale testing (Phase 3)Study completedNCT03139604
What this trial is testing

GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 439
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07750574
What this trial is testing

Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis

Who this might be right for
MyelofibrosisMyelofibrosis Due to and Following Polycythemia VeraMyelofibrosis Transformation in Essential Thrombocythemia+9 more
Chengdu Zenitar Biomedical Technology Co., Ltd 105
Early research (Phase 1)UnknownNCT05279001
What this trial is testing

A Safety and Tolerability Study of Jaktinib

Who this might be right for
Myelofibrosis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 26
Testing effectiveness (Phase 2)Looking for participantsNCT06887803
What this trial is testing

Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

Who this might be right for
Myelofibrosis (MF)
iOnctura 26
Large-scale testing (Phase 3)Looking for participantsNCT07357727
What this trial is testing

Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals 460
Testing effectiveness (Phase 2)Study completedNCT05247489
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo

Who this might be right for
Vitiligo
Incyte Corporation 55
Not applicableStudy completedNCT03208803
What this trial is testing

Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis

Who this might be right for
Myelofibrosis; Anemia
Centre Hospitalier Annecy Genevois 65
Not applicableLooking for participantsNCT06627335
What this trial is testing

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

Who this might be right for
Pregnancy RelatedAtopic Dermatitis
Incyte Corporation 5,621
Large-scale testing (Phase 3)Ended earlyNCT03584516
What this trial is testing

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Incyte Corporation 155
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Not applicableLooking for participantsNCT06259669
What this trial is testing

Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

Who this might be right for
Pregnancy RelatedAtopic Dermatitis
Incyte Corporation 958
Next Page